Press Releases on November 9, 2023 - EIN Presswire - Press Release Distribution Service

Published on November 9, 2023 - 21:05 GMT

Sientra Reports Third Quarter Financial and Operational Results

IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its financial …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:05 GMT

HeartCore’s Subsidiary Sigmaways Engages with Heart-Tech Health and Coherent Health

NEW YORK and TOKYO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced that its subsidiary, Sigmaways, Inc. (“ …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

OrthoPediatrics Corp. to Participate in Upcoming November Conferences

WARSAW, Ind., Nov. 09, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced that Dave Bailey, President & Chief Executive Officer, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:05 GMT

Applied Optoelectronics Reports Third Quarter 2023 Results

SUGAR LAND, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the cable broadband, internet datacenter, telecom and fiber-to-the-home (FTTH) markets, today …

Distribution channels: Business & Economy, Electronics Industry ...

Published on November 9, 2023 - 21:05 GMT

RxSight, Inc. Reports Third Quarter 2023 Financial Results

ALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates

Continues to report clinical and preclinical findings supporting the potential benefits of its small molecule therapeutic candidates targeting the neurotrophic HGF system as potential novel treatments for neurodegenerative diseases Expects to complete …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:05 GMT

Hydrofarm Holdings Group Announces Third Quarter 2023 Results

SHOEMAKERSVILLE, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled …

Distribution channels: Business & Economy, Electronics Industry ...

Published on November 9, 2023 - 21:05 GMT

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Positive interim 12-week safety and efficacy data reported from Phase 2a INTEGRIS-PSC trial in patients with PSC Positive DSMB safety review recommends INTEGRIS-PSC trial continue without modification Key Clinical Development and Regulatory appointments …

Distribution channels: Business & Economy, Companies ...

Published on November 9, 2023 - 21:05 GMT

Dianthus Therapeutics Highlights Recent Business Achievements and Third Quarter 2023 Financial Results

Began trading on Nasdaq under the ticker symbol DNTH following the successful completion of our merger with Magenta Therapeutics Completed concurrent $72 million financing with a syndicate of leading life-science investors Announced positive top-line Phase …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

Phunware Reports Third Quarter 2023 Financial Results

AUSTIN, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or the “Company,” “we,” “us” or “our”), the pioneer of Location Based SaaS that offers the only fully integrated enterprise cloud platform for mobile that enables …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

ClearPoint Neuro Reports Third Quarter 2023 Results

SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its third …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:05 GMT

Navitas Semiconductor Announces Third Quarter 2023 Financial Results

Revenue grows 115% year-over-year, 22% sequentially. Launching four new technology platforms. GaN and SiC continue rapid displacement of legacy silicon power chips. TORRANCE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Navitas Semiconductor Corporation ( …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2024

SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes, today reported financial results for its first fiscal quarter ended …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results

-- Cash runway extended into Q2 2024 -- -- Company to host call at 4:30pm today -- NEWTOWN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

BOSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of T cell engagers to selectively modulate tumor-specific T cells, provided a business and financial update for …

Distribution channels:

Published on November 9, 2023 - 21:05 GMT

Synaptics Reports First Quarter Fiscal 2024 Results

Q1’24 Financial Results and Recent Business Highlights Revenue of $237.7 million GAAP gross margin of 45.1 percent Non-GAAP gross margin of 53.0 percent GAAP loss per share of $1.43 Non-GAAP diluted earnings per share of $0.52 SAN JOSE, Calif., Nov. 09, …

Distribution channels: Business & Economy, Technology ...

Published on November 9, 2023 - 21:05 GMT

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed ...

Phase 1 trial to investigate multiple B-cell mediated autoimmune diseases First healthy donor-derived allogeneic CAR T cell therapy to announce IND clearance Expect to disclose initial clinical data next year SEATTLE, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sana …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:05 GMT

Epsilon Reports Third Quarter 2023 Results

HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported third quarter 2023 financial and operating results. Third Quarter Financial Highlights: Reported net revenue interest (NRI) production …

Distribution channels: Business & Economy ...

Published on November 9, 2023 - 21:05 GMT

Lisata Therapeutics Announces Participation in Upcoming Conferences in November

BASKING RIDGE, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:05 GMT

Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update

During the 2023 field season, Cibus completed extensive field trials for its three developed traits, PSR in canola and HT1 and HT3 in rice. Company also reports continued progress of Cibus’ high-throughput soybean editing system and its two advanced traits …

Distribution channels: